225 related articles for article (PubMed ID: 12933858)
81. Attaching and effacing enteropathogenic Escherichia coli O18ab invades epithelial cells and causes persistent diarrhea.
Scaletsky IC; Pedroso MZ; Fagundes-Neto U
Infect Immun; 1996 Nov; 64(11):4876-81. PubMed ID: 8890257
[TBL] [Abstract][Full Text] [Related]
82. Free secretory component and lactoferrin of human milk inhibit the adhesion of enterotoxigenic Escherichia coli.
Giugliano LG; Ribeiro ST; Vainstein MH; Ulhoa CJ
J Med Microbiol; 1995 Jan; 42(1):3-9. PubMed ID: 7739021
[TBL] [Abstract][Full Text] [Related]
83. The enteropathogenic E. coli effector EspB facilitates microvillus effacing and antiphagocytosis by inhibiting myosin function.
Iizumi Y; Sagara H; Kabe Y; Azuma M; Kume K; Ogawa M; Nagai T; Gillespie PG; Sasakawa C; Handa H
Cell Host Microbe; 2007 Dec; 2(6):383-92. PubMed ID: 18078690
[TBL] [Abstract][Full Text] [Related]
84. TccP2-mediated subversion of actin dynamics by EPEC 2 - a distinct evolutionary lineage of enteropathogenic Escherichia coli.
Whale AD; Hernandes RT; Ooka T; Beutin L; Schüller S; Garmendia J; Crowther L; Vieira MAM; Ogura Y; Krause G; Phillips AD; Gomes TAT; Hayashi T; Frankel G
Microbiology (Reading); 2007 Jun; 153(Pt 6):1743-1755. PubMed ID: 17526832
[TBL] [Abstract][Full Text] [Related]
85. Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection.
Donnenberg MS; Tacket CO; James SP; Losonsky G; Nataro JP; Wasserman SS; Kaper JB; Levine MM
J Clin Invest; 1993 Sep; 92(3):1412-7. PubMed ID: 8376594
[TBL] [Abstract][Full Text] [Related]
86. Enterohaemorrhagic and enteropathogenic Escherichia coli use a different Tir-based mechanism for pedestal formation.
DeVinney R; Puente JL; Gauthier A; Goosney D; Finlay BB
Mol Microbiol; 2001 Sep; 41(6):1445-58. PubMed ID: 11580847
[TBL] [Abstract][Full Text] [Related]
87. Role of BfpF, a member of the PilT family of putative nucleotide-binding proteins, in type IV pilus biogenesis and in interactions between enteropathogenic Escherichia coli and host cells.
Anantha RP; Stone KD; Donnenberg MS
Infect Immun; 1998 Jan; 66(1):122-31. PubMed ID: 9423848
[TBL] [Abstract][Full Text] [Related]
88. Adhesion and its role in the virulence of enteropathogenic Escherichia coli.
Law D
Clin Microbiol Rev; 1994 Apr; 7(2):152-73. PubMed ID: 8055465
[TBL] [Abstract][Full Text] [Related]
89. Presence of the LEE (locus of enterocyte effacement) in pig attaching and effacing Escherichia coli and characterization of eae, espA, espB and espD genes of PEPEC (pig EPEC) strain 1390.
An H; Fairbrother JM; Désautels C; Mabrouk T; Dugourd D; Dezfulian H; Harel J
Microb Pathog; 2000 May; 28(5):291-300. PubMed ID: 10799279
[TBL] [Abstract][Full Text] [Related]
90. Competitive inhibition of adherence of enterotoxigenic Escherichia coli, enteropathogenic Escherichia coli and Clostridium difficile to intestinal epithelial cell line Lovo by purified adhesin of Bifidobacterium adolescentis 1027.
Zhong SS; Zhang ZS; Wang JD; Lai ZS; Wang QY; Pan LJ; Ren YX
World J Gastroenterol; 2004 Jun; 10(11):1630-3. PubMed ID: 15162538
[TBL] [Abstract][Full Text] [Related]
91. Screening for enteropathogenic Escherichia coli in infants with diarrhea by the fluorescent-actin staining test.
Knutton S; Phillips AD; Smith HR; Gross RJ; Shaw R; Watson P; Price E
Infect Immun; 1991 Jan; 59(1):365-71. PubMed ID: 1702763
[TBL] [Abstract][Full Text] [Related]
92. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells.
Kenny B; DeVinney R; Stein M; Reinscheid DJ; Frey EA; Finlay BB
Cell; 1997 Nov; 91(4):511-20. PubMed ID: 9390560
[TBL] [Abstract][Full Text] [Related]
93. Genetic and phenotypic analysis of Escherichia coli with enteropathogenic characteristics isolated from Seattle children.
Bokete TN; Whittam TS; Wilson RA; Clausen CR; O'Callahan CM; Moseley SL; Fritsche TR; Tarr PI
J Infect Dis; 1997 Jun; 175(6):1382-9. PubMed ID: 9180177
[TBL] [Abstract][Full Text] [Related]
94. Antigen detection in enteropathogenic Escherichia coli using secretory immunoglobulin A antibodies isolated from human breast milk.
Manjarrez-Hernandez HA; Gavilanes-Parra S; Chavez-Berrocal E; Navarro-Ocaña A; Cravioto A
Infect Immun; 2000 Sep; 68(9):5030-6. PubMed ID: 10948121
[TBL] [Abstract][Full Text] [Related]
95. Host cell death due to enteropathogenic Escherichia coli has features of apoptosis.
Crane JK; Majumdar S; Pickhardt DF
Infect Immun; 1999 May; 67(5):2575-84. PubMed ID: 10225923
[TBL] [Abstract][Full Text] [Related]
96. Enteropathogenic Escherichia coli markedly decreases the resting membrane potential of Caco-2 and HeLa human epithelial cells.
Stein MA; Mathers DA; Yan H; Baimbridge KG; Finlay BB
Infect Immun; 1996 Nov; 64(11):4820-5. PubMed ID: 8890244
[TBL] [Abstract][Full Text] [Related]
97. Enteropathogenic E. coli effectors EspG1/G2 disrupt tight junctions: new roles and mechanisms.
Glotfelty LG; Hecht GA
Ann N Y Acad Sci; 2012 Jul; 1258():149-58. PubMed ID: 22731728
[TBL] [Abstract][Full Text] [Related]
98. Enteropathogenic Escherichia coli protein secretion is induced in response to conditions similar to those in the gastrointestinal tract.
Kenny B; Abe A; Stein M; Finlay BB
Infect Immun; 1997 Jul; 65(7):2606-12. PubMed ID: 9199427
[TBL] [Abstract][Full Text] [Related]
99. Effect of lactoferrin on enteric pathogens.
Ochoa TJ; Cleary TG
Biochimie; 2009 Jan; 91(1):30-4. PubMed ID: 18472012
[TBL] [Abstract][Full Text] [Related]
100. Calcium-calmodulin dependence of actin accretion and lethality in cultured HEp-2 cells infected with enteropathogenic Escherichia coli.
Baldwin TJ; Lee-Delaunay MB; Knutton S; Williams PH
Infect Immun; 1993 Feb; 61(2):760-3. PubMed ID: 8423102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
